Skip to main content Back to Top
Advertisement

7/1/2019

0.9% Sodium Chloride 10 mL, 20 mL, and 50 mL Preservative Free Vials and Syringes

Products Affected - Description

    • 0.9% Sodium Chloride solution for injection, Fresenius Kabi, 20 mL single dose vial, 25 count, NDC 63323-0186-20
    • 0.9% Sodium Chloride solution for injection, Pfizer, 50 mL single dose vial, 25 count, NDC 00409-4888-50

Reason for the Shortage

    • Fresenius Kabi has recalled multiple lots of 0.9% sodium chloride 10 mL and 20 mL vials due to labels incorrectly stating the stoppers are latex-free. The letter and the lot numbers affected can be found at https://www.fresenius-kabi.com/us/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-sodium.
    • Pfizer has 0.9% sodium chloride preservative-free vials on shortage due to manufacturing delays.

Available Products

    • 0.9% Sodium Chloride solution for injection, Fresenius Kabi, 10 mL single dose vial, 25 count, NDC 63323-0186-10
    • 0.9% Sodium Chloride solution for injection, Medefil, Inc., 10 mL syringe, 60 count, NDC 64253-0202-30
    • 0.9% Sodium Chloride solution for injection, Pfizer, 10 mL Life-Shield single dose vial, 25 count, NDC 00409-4888-12
    • 0.9% Sodium Chloride solution for injection, Pfizer, 10 mL single dose vial, 25 count, NDC 00409-4888-10
    • 0.9% Sodium Chloride solution for injection, Pfizer, 20 mL single dose vial, 25 count, NDC 00409-4888-20

Estimated Resupply Dates

    • Fresenius Kabi has 0.9% sodium chloride preservative free 20 mL vials on back order and the company estimates a release date of mid-July 2019.
    • Pfizer has 0.9% sodium chloride preservative free 50 mL vials on back order and the company estimates a release date of July 2019.

Updated

Updated July 1, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 12, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins